CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Massachusetts General Hospital
Boston, Estados UnidosPublications en collaboration avec des chercheurs de Massachusetts General Hospital (6)
2024
-
Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Frontiers in Neurology, Vol. 15
-
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis
Journal of Neurology, Vol. 271, Núm. 8, pp. 4794-4812
2023
-
Ravulizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Annals of Neurology, Vol. 93, Núm. 6, pp. 1053-1068
2022
-
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
Multiple Sclerosis Journal, Vol. 28, Núm. 3, pp. 480-486
2021
-
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD
Annals of Neurology, Vol. 89, Núm. 6, pp. 1088-1098
2020
-
Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
Frontiers in Pediatrics, Vol. 8